Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Staphylococcus spp. bacterial surface receptors, most notably the Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs), are a diverse array of proteins covalently anchored to the bacterial cell wall that mediate critical interactions with the host environment (Wikipedia, 2024; NIH, 2019). These receptors are fundamental to the pathogenesis of staphylococcal species, such as Staphylococcus aureus and Staphylococcus epidermidis, by facilitating adhesion to host extracellular matrix components like fibrinogen, fibronectin, and collagen (NIH, 2019; ResearchGate, 2022). This attachment is the prerequisite for tissue colonization and the development of persistent biofilms on medical devices and heart valves (NIH, 2025; NIH, 2019). In addition to their adhesive properties, these surface receptors contribute to immune evasion—exemplified by Protein A (SpA) binding to the Fc region of antibodies—and nutrient acquisition, such as the Isd system's role in extracting iron from host hemoglobin (NIH, 2017; NIH, 2018). Because of their essential roles in virulence and their exposure on the bacterial exterior, these receptors are targeted by experimental monoclonal antibodies like tefibazumab and vaccines like V710 designed to disrupt infection and enhance bacterial clearance (Wikipedia, 2024; NIH, 2018). However, the therapeutic targeting of these receptors is complicated by the high degree of functional redundancy and genetic diversity across different staphylococcal strains (NIH, 2019; IntechOpen, 2017).
Inhibition of bacterial adhesion to host tissues, neutralization of immune evasion factors, opsonization for phagocytosis, disruption of biofilm formation, and prevention of iron uptake.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Staphylococcus spp. bacterial surface receptors (MSCRAMMs).